Nectar Lifesciences trades with traction on the BSE

19 Mar 2015 Evaluate

Nectar Lifesciences is currently trading at Rs. 42.60, up by 0.80 points or 1.91% from its previous closing of Rs. 41.80 on the BSE.

The scrip opened at Rs. 42.50 and has touched a high and low of Rs. 44.00 and Rs. 42.35 respectively. So far 310607 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 1 has touched a 52 week high of Rs. 44.65 on 16-Sep-2014 and a 52 week low of Rs. 18.10 on 19-Mar-2014.

Last one week high and low of the scrip stood at Rs. 44.00 and Rs. 35.00 respectively. The current market cap of the company is Rs. 968.81 crore.

The promoters holding in the company stood at 44.35% while Institutions and Non-Institutions held 14.62% and 20.51% respectively.

Nectar Lifesciences has been chosen as the Fastest Growing Pharmaceutical Company in 2014 by CNBC TV-18 in partnership with State Bank of India (SBI) during the 5th edition international trade awards held in Ludhiana. The advisors for this award were ICRA. The citation was awarded under Aegis of Export Import Forum of India. The company has maintained a CAGR of 25% for last 10 years.

Nectar Lifesciences is a $311 million pharmaceutical organization. The company offers a range of Cephalosporin active pharmaceutical ingredients (APIs) and finished dosage forms.

Nectar Lifesciences Share Price

39.11 1.76 (4.71%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.